Engin Yapici·Apr 21I Stress-Tested the AWS-MSK Nanobody Paper. These Are the Gaps.Technical analysis of an agent-guided de novo nanobody design campaign
Engin Yapici·Jan 20Origin-1: Absci’s De Novo Antibody Design PlatformMicromolar hits with structural validation but therapeutic gaps.
Engin Yapici·Dec 30, 2025Low Immunogenicity in Human Panels? Examining Latent-X2’s EvidenceAnalyzing the immunogenicity assay quality and binding validation in the first AI antibody study to test human immune responses
Engin Yapici·Dec 2, 2025JAM-2: Performance Metrics and Validation GapsTechnical analysis of Nabla Bio’s computational antibody design platform
KNect365 Life Sciences·Nov 2, 2018What’s the future of monoclonal antibodies? [WHITEPAPER]According to BIS Research and Research and Markets, monoclonal antibodies (mAbs) are expected to make up just under half of the USD $22.7…
KNect365 Life Sciences·Nov 2, 2018[Industry Report] Current trends in Antibody Engineering and Therapeutics 2018A recent survey was conducted by KNect365 Life Sciences (Aug 2018) and administered to antibody therapeutics professionals from across…
Avery Lee·Jul 7, 2017The Complete Guide to Development of Antibody EngineeringThe advancement of therapeutic antibodies has included numerous engineering endeavors in the expectation of enhancing the adequacy…
